FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1887675281> ?p ?o ?g. }

• W1887675281 endingPage "701" @default.
• W1887675281 startingPage "694" @default.
• W1887675281 abstract "Purpose To study quality of life (QoL) in responders and nonresponders after radiation therapy for painful bone metastases; and to identify factors predictive for a pain response. Patients and Methods The prospectively collected data of 956 patients with breast, prostate, and lung cancer within the Dutch Bone Metastasis Study were used. These patients, irradiated for painful bone metastases, rated pain, QoL, and overall health at baseline and weekly afterward for 12 weeks. Using generalized estimating equations analysis, the course of QoL was studied, adjusted for primary tumor. To identify predictive variables, proportional hazard analyses were performed, taking into account death as a competing risk, and C-statistics were calculated for discriminative value. Results In total, 722 patients (76%) responded to radiation therapy. During follow-up, responders had a better QoL in all domains compared with nonresponders. Patients with breast or prostate cancer had a better QoL than patients with lung cancer. In multivariate analysis, baseline predictors for a pain response were breast or prostate cancer as primary tumor, younger age, good performance status, absence of visceral metastases, and using opioids. The discriminative ability of the model was low (C-statistic: 0.56). Conclusions Responding patients show a better QoL after radiation therapy for painful bone metastases than nonresponders. Our model did not have enough discriminative power to predict which patients are likely to respond to radiation therapy. Therefore, radiation therapy should be offered to all patients with painful bone metastases, aiming to decrease pain and improve QoL. To study quality of life (QoL) in responders and nonresponders after radiation therapy for painful bone metastases; and to identify factors predictive for a pain response. The prospectively collected data of 956 patients with breast, prostate, and lung cancer within the Dutch Bone Metastasis Study were used. These patients, irradiated for painful bone metastases, rated pain, QoL, and overall health at baseline and weekly afterward for 12 weeks. Using generalized estimating equations analysis, the course of QoL was studied, adjusted for primary tumor. To identify predictive variables, proportional hazard analyses were performed, taking into account death as a competing risk, and C-statistics were calculated for discriminative value. In total, 722 patients (76%) responded to radiation therapy. During follow-up, responders had a better QoL in all domains compared with nonresponders. Patients with breast or prostate cancer had a better QoL than patients with lung cancer. In multivariate analysis, baseline predictors for a pain response were breast or prostate cancer as primary tumor, younger age, good performance status, absence of visceral metastases, and using opioids. The discriminative ability of the model was low (C-statistic: 0.56). Responding patients show a better QoL after radiation therapy for painful bone metastases than nonresponders. Our model did not have enough discriminative power to predict which patients are likely to respond to radiation therapy. Therefore, radiation therapy should be offered to all patients with painful bone metastases, aiming to decrease pain and improve QoL." @default.
• W1887675281 created "2016-06-24" @default.
• W1887675281 creator A5010049892 @default.
• W1887675281 creator A5011488517 @default.
• W1887675281 creator A5014228703 @default.
• W1887675281 creator A5014743334 @default.
• W1887675281 creator A5015454785 @default.
• W1887675281 creator A5017996394 @default.
• W1887675281 creator A5048377574 @default.
• W1887675281 creator A5068401090 @default.
• W1887675281 date "2015-11-01" @default.
• W1887675281 modified "2023-10-14" @default.
• W1887675281 title "Quality of Life in Relation to Pain Response to Radiation Therapy for Painful Bone Metastases" @default.
• W1887675281 cites W1496845098 @default.
• W1887675281 cites W1785893016 @default.
• W1887675281 cites W1974160564 @default.
• W1887675281 cites W1981329116 @default.
• W1887675281 cites W1991902238 @default.
• W1887675281 cites W1993494057 @default.
• W1887675281 cites W1994769053 @default.
• W1887675281 cites W1995247480 @default.
• W1887675281 cites W2018038855 @default.
• W1887675281 cites W2018255531 @default.
• W1887675281 cites W2019300001 @default.
• W1887675281 cites W2025749457 @default.
• W1887675281 cites W2027673233 @default.
• W1887675281 cites W2032059530 @default.
• W1887675281 cites W2037624654 @default.
• W1887675281 cites W2038446169 @default.
• W1887675281 cites W2038981426 @default.
• W1887675281 cites W2042080283 @default.
• W1887675281 cites W2042823833 @default.
• W1887675281 cites W2062177623 @default.
• W1887675281 cites W2082233982 @default.
• W1887675281 cites W2084874632 @default.
• W1887675281 cites W2095286102 @default.
• W1887675281 cites W2100207941 @default.
• W1887675281 cites W2108145085 @default.
• W1887675281 cites W2108828428 @default.
• W1887675281 cites W2113235727 @default.
• W1887675281 cites W2126121630 @default.
• W1887675281 cites W2129925362 @default.
• W1887675281 cites W2136392842 @default.
• W1887675281 cites W2139879375 @default.
• W1887675281 cites W2154313997 @default.
• W1887675281 cites W2160655505 @default.
• W1887675281 cites W2165053393 @default.
• W1887675281 doi "https://doi.org/10.1016/j.ijrobp.2015.06.024" @default.
• W1887675281 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26281825" @default.
• W1887675281 hasPublicationYear "2015" @default.
• W1887675281 type Work @default.
• W1887675281 sameAs 1887675281 @default.
• W1887675281 citedByCount "52" @default.
• W1887675281 countsByYear W18876752812016 @default.
• W1887675281 countsByYear W18876752812017 @default.
• W1887675281 countsByYear W18876752812018 @default.
• W1887675281 countsByYear W18876752812019 @default.
• W1887675281 countsByYear W18876752812020 @default.
• W1887675281 countsByYear W18876752812021 @default.
• W1887675281 countsByYear W18876752812022 @default.
• W1887675281 countsByYear W18876752812023 @default.
• W1887675281 crossrefType "journal-article" @default.
• W1887675281 hasAuthorship W1887675281A5010049892 @default.
• W1887675281 hasAuthorship W1887675281A5011488517 @default.
• W1887675281 hasAuthorship W1887675281A5014228703 @default.
• W1887675281 hasAuthorship W1887675281A5014743334 @default.
• W1887675281 hasAuthorship W1887675281A5015454785 @default.
• W1887675281 hasAuthorship W1887675281A5017996394 @default.
• W1887675281 hasAuthorship W1887675281A5048377574 @default.
• W1887675281 hasAuthorship W1887675281A5068401090 @default.
• W1887675281 hasConcept C121608353 @default.
• W1887675281 hasConcept C126322002 @default.
• W1887675281 hasConcept C143998085 @default.
• W1887675281 hasConcept C159110408 @default.
• W1887675281 hasConcept C1862650 @default.
• W1887675281 hasConcept C2776256026 @default.
• W1887675281 hasConcept C2777783956 @default.
• W1887675281 hasConcept C2779951463 @default.
• W1887675281 hasConcept C2780192828 @default.
• W1887675281 hasConcept C38180746 @default.
• W1887675281 hasConcept C509974204 @default.
• W1887675281 hasConcept C530470458 @default.
• W1887675281 hasConcept C71924100 @default.
• W1887675281 hasConceptScore W1887675281C121608353 @default.
• W1887675281 hasConceptScore W1887675281C126322002 @default.
• W1887675281 hasConceptScore W1887675281C143998085 @default.
• W1887675281 hasConceptScore W1887675281C159110408 @default.
• W1887675281 hasConceptScore W1887675281C1862650 @default.
• W1887675281 hasConceptScore W1887675281C2776256026 @default.
• W1887675281 hasConceptScore W1887675281C2777783956 @default.
• W1887675281 hasConceptScore W1887675281C2779951463 @default.
• W1887675281 hasConceptScore W1887675281C2780192828 @default.
• W1887675281 hasConceptScore W1887675281C38180746 @default.
• W1887675281 hasConceptScore W1887675281C509974204 @default.
• W1887675281 hasConceptScore W1887675281C530470458 @default.
• W1887675281 hasConceptScore W1887675281C71924100 @default.
• W1887675281 hasIssue "3" @default.
• W1887675281 hasLocation W18876752811 @default.

• next